---
title: "The public offering of HAIXI PHARMA was oversubscribed by 3,164 times, listing on Monday"
description: "HAIXI PHARMA's public offering was oversubscribed by 3,165 times and is scheduled to be listed on Monday (20th). The results of the offering show that the subscription rate for the Hong Kong public of"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/261768688.md"
published_at: "2025-10-19T11:35:50.000Z"
---

# The public offering of HAIXI PHARMA was oversubscribed by 3,164 times, listing on Monday

> HAIXI PHARMA's public offering was oversubscribed by 3,165 times and is scheduled to be listed on Monday (20th). The results of the offering show that the subscription rate for the Hong Kong public offering was 1%, while the international offering was subscribed 6.3 times, with a final offer price of HKD 86.4, raising a net amount of HKD 940 million. This global offering consisted of 11.5 million H shares, with 10% allocated for public offering. Cornerstone investor Harvest Oriental SP subscribed for 1.9817 million shares, with a lock-up commitment until April 19, 2026

The originally planned listing of HAIXI PHARMA (02637.HK) on last Friday (17th) announced its IPO results, with the Hong Kong public offering receiving 3,165.1 times subscription, a 1% chance of winning for one board lot (50 shares), and a subscription of 300,000 shares required to secure one board lot. The international offering recorded 6.3 times subscription. The final offer price was HKD 86.4, at the upper limit of the price range, raising a net amount of HKD 940 million. The shares are expected to be listed on Monday (20th).

Innovative pharmaceutical company HAIXI PHARMA plans to globally offer 11.5 million H shares, with the public offering accounting for 10%. The offer price ranged from HKD 69.88 to HKD 86.4. Cornerstone investor Harvest Oriental SP subscribed for 1.9817 million shares, accounting for 17.23% of the total offering. The final date for the lock-up commitment is April 19, 2026

### Related Stocks

- [02637.HK - HAIXI PHARMA](https://longbridge.com/en/quote/02637.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 閲文集團是否會翻開新篇章？ | 閲文集團預計去年淨虧損高達 8.5 億元，主要由於收購新經典傳媒時計提了 18 億元的商譽減值。該公司的股票經歷了顯著的波動，在達到每股 45.50 港元的高點後下跌了 20%，並在發佈盈利預警後最近又下跌了 8%。儘管面臨收入和核心業務下 | [Link](https://longbridge.com/en/news/276113491.md) |
| 摩爾線程快速完成對 Qwen3.5 模型全面適配 | 摩爾線程宣佈已在旗艦級 AI 訓推一體全功能 GPU MTT S5000 上完成對阿里最新大模型 Qwen3.5 的全方位適配。此次支持充分展示了摩爾線程 MUSA 生態的成熟度與完備性，開發者可通過 MUSA C 編程語言及 Triton | [Link](https://longbridge.com/en/news/276153560.md) |
| 加拿大宣佈新國防工業戰略，注重國內製造以重獲戰備能力 | 加拿大總理卡尼於 2 月 17 日宣佈新的國防工業戰略，設定未來十年目標，包括將 70% 的國防合同授予本國企業，旨在實現國內採購和維護大部分軍事裝備。 | [Link](https://longbridge.com/en/news/276178964.md) |
| 特斯拉首輛 Cybercab 下線：沒有方向盤和踏板的汽車終於來了 | 特斯拉宣佈，首輛賽博無人駕駛電動車 Tesla Cybercab 在美國得州超級工廠正式下線。風險提示及免責條款 市場有風險，投資需謹慎。本文不構成個人投資建議，也未考慮到個別用户特殊的投資目標、財務狀況或需要。用户應考慮本文中的任何意見、 | [Link](https://longbridge.com/en/news/276188665.md) |
| Meta 加碼英偉達：未來數年部署數百萬顆芯片，首次採用 Grace CPU | 根據週二發佈的聲明，Meta 承諾將使用更多來自英偉達的 AI 處理器和網絡設備。同時，Meta 還將首次在其獨立計算機的核心部件採用英偉達的 Grace CPU。此次部署將涵蓋基於英偉達當前 Blackwell 架構，以及即將推出的 Ve | [Link](https://longbridge.com/en/news/276177748.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.